BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160408
DTEND;VALUE=DATE:20160409
DTSTAMP:20160111T211359Z
CREATED:20151218T191804Z
LAST-MODIFIED:20160111T211359Z
UID:11958-1460073600-1460159999@ces.b2sg.org
SUMMARY:Ruth L- Kirschstein National Research service F30 Award
DESCRIPTION:The NCI Ruth L. Kirschstein National Research service F30 Award supports promising doctoral candidates who will perform dissertation research and training for an MD/PhD degree in a scientific health-related field relevant to the mission of the NCI during the tenure of the award. Applicants for the F30 must be within 48 months of matriculation into an accredited MD/PhD program at the time of application. \nNCI requires a clear cancer focus in graduate research training and gives funding priority to applications whose primary sponsor has cancer-related R01 or R01-like\, peer-reviewed research grants at the time of application and the time of the award. For the NCI F30 Award\, R01-like research funding includes peer-reviewed research grants from other federal sources and private foundations with a duration of at least 3 years with a minimum of $150\,000 direct costs per year. The primary sponsor is expected to maintain such grant support during the project period. Grants under a no-cost extension do not qualify. \nReminder to NCI Fellowship grantees: Changes in the Project\nIndividual fellowship awards are made for training at a specific institution under the guidance of a particular sponsor. Prior approval by NCI is required for a transfer of the award to another institution\, a change in sponsor\, or a significant project change. If the primary sponsor plans to be absent for a continuous period of more than 3 months\, an interim sponsor must be named by the institution and approved in writing by NCI.
URL:https://ces.b2sg.org/event/ruth-l-kirschstein-national-research-service-f30-award/
CATEGORIES:Awards
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/NCI.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160419
DTEND;VALUE=DATE:20160423
DTSTAMP:20160419T155206Z
CREATED:20151230T044217Z
LAST-MODIFIED:20160419T155206Z
UID:12186-1461024000-1461369599@ces.b2sg.org
SUMMARY:3rd Annual Epigenetic  Inhibitor Discovery  - Targeting Histone Methyltransferases\, Demethylases and Bromodomains
DESCRIPTION:Targeting epigenetic modifiers and readers\, particularly histone methyltransferases\, demethylases and bromodomain-containing proteins have recently set the foundation for a new generation of anti-cancer drugs. Over the past few years\, several companies have developed and successfully moved novel compounds targeting EZH2\, DOT1L\, LSD1\, and a collection of BET bromodomain inhibitors into clinical studies. As these compounds continue to progress\, developers are now focused on the discovery of new targets and designing novel inhibitors to expand into this robust target space. Of particular interest for discovery are non-BET bromodomain proteins and methyl lysine readers; arginine methyltransferases; and JmjC-domain containing demethylases. \nCambridge Healthtech Institute will once again convene leaders in Epigenetic Inhibitor Discovery to bring forth novel and emerging strategies for inhibition\, new bioactive tools and inhibitors\, as well as strategies for lead optimization to obtain clinically relevant small molecules.
URL:https://ces.b2sg.org/event/3th-annual-epigenetic-inhibitor-discovery-targeting-histone-methyltransferases-demethylases-and-bromodomains/
LOCATION:Hilton San Diego Resort and Spa\, San Diego\, CA\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2015/12/crop-drug.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160424
DTEND;VALUE=DATE:20160429
DTSTAMP:20160419T160331Z
CREATED:20151230T044602Z
LAST-MODIFIED:20160419T160331Z
UID:12189-1461456000-1461887999@ces.b2sg.org
SUMMARY:Game of Epigenomics
DESCRIPTION:The ‘Game of Epigenomics’ conference will celebrate the great diversity in the epigenomics field\, reflecting both on DNA and protein modifications. The conference will host international and national leaders in the field\, covering the spectrum of epigenomic research\, presenting data from diverse model systems as well as clinical research and new insights in disease epigenomics. The conference will move from basic epigenetic mechanisms and chromatin structure\, epigenomics and epigenomic technologies to clinical and translational epigenetics. \nThe historic town of Dubrovnik will play host to an Epigenomics conference for the first time. Also\, the conference will mark the closure of the InnoMol project\, and will enable a final brainstorming of InnoMol partnering institutions\, but also give an opportunity for new networking between world class scientists during our Game of Epigenomics. \nThus\, we will create an atmosphere with cutting edge science highlighting the latest developments in the epigenomics field\, support extensive scientific discussions\, and ample possibilities for socializing\, networking and also exploring the remarkable surrounds. Picturesque Dubrovnik\, host town of the world famous TV show ‘Game of Thrones’ is situated on the very South of Croatia. Surrounded by crystal clear Adriatic sea it is also known as the Pearl of Dalmatia.
URL:https://ces.b2sg.org/event/game-of-epigenomics/
LOCATION:Unnamed Venue\, Dubrovnik\, Croatia (Local Name: Hrvatska)
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2015/12/game-of-epigenetics.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20160429
DTEND;VALUE=DATE:20160430
DTSTAMP:20160419T155753Z
CREATED:20160419T011244Z
LAST-MODIFIED:20160419T155753Z
UID:14882-1461888000-1461974399@ces.b2sg.org
SUMMARY:The search for the best cancer research in the world
DESCRIPTION:Since 1979 “worldwide cancer research” has invested into nearly two thousand reseach projects all over the world. The goal of this grant is to support research that might in future help reduce the incidence of cancer or improve cancer survial. \nGrants are awarded to support fudamental or translational research into the causes\, mechanisms\, diagnosis\, treatment or prevention of cancer. \nDuration of funding: 1-3years \nCovered costs: direct costs of conducting the research \nNationality: international
URL:https://ces.b2sg.org/event/the-search-for-the-best-cancer-research-in-the-world/
CATEGORIES:Grants
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/04/worldwide-cancer-research1.png
END:VEVENT
END:VCALENDAR